RP Check (RP01)
MD Diagnostics, Ltd. · Decision date Oct 26, 2026
What did the FDA decide?
FDA recorded a substantially equivalent decision for K260671, RP Check (RP01), submitted by MD Diagnostics, Ltd., with a decision date of 2026-10-26. The listing places the submission under the Anesthesiology specialty with product code CAP. Substantially equivalent in the 510(k) pathway denotes clearance to market, not premarket approval of a new device.
The available record identifies the device by trade name and model designation only. It does not describe the device's components, intended use, technological characteristics, or any predicate device, and no summary of the cleared indications is present in the source. The relationship to any earlier submission by this applicant is likewise unstated. Researchers should treat the clearance scope as unknown pending the underlying FDA decision documents.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Anesthesiology
- Decision date
- Oct 26, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260671
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- MD Diagnostics, Ltd.
- Product code
- CAP
- Decision code
- SESE
- Decision date
- Oct 26, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Monitor, Airway Pressure (Includes Gauge And/Or Alarm).
- Applicant
- MD Diagnostics, Ltd.
- Product code
- CAP
- FDA device class
- 2
FDA decision timeline
K260671 received
Application receipt date recorded by FDA.
K260671 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
MD Diagnostics, Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Chatham
Sources and methodology
- Original FDA record: K260671
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records